文献速递儿科与产科急症心脑血管急症重症综合管理与镇静镇痛

美国儿科患者先天性与获得性心血管疾病与COVID-19严重程度的关联

Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in the US.
PubMed 文献 · JAMA Netw Open · 2022-05-02
一句话结论回顾性队列研究显示,既往心脏骤停(OR 9.92)、心源性休克(OR 3.07)等心血管疾病与儿科COVID-19重症风险升高相关。

该回顾性队列研究利用美国85个医疗系统的电子健康记录数据库,纳入2020年3月1日至2021年1月31日期间年龄2个月至17岁、实验室确诊COVID-19或诊断编码提示SARS-CoV-2感染或暴露的171 416例儿科患者。暴露为2015年1月1日至2019年12月31日(SARS-CoV-2感染前)诊断的26种心血管疾病,主要结局为需要补充氧气或院内死亡定义的COVID-19重症。混合效应随机截距logistic回归显示,既往心脏骤停(OR 9.92;95%CI 6.93-14.20)、心源性休克(OR 3.07;95%CI 1.90-4.96)、心脏手术(OR 3.04;95%CI 2.26-4.08)等13种心血管疾病与重症COVID-19相关。作者认为,部分既往或既存心血管疾病与美国儿科患者COVID-19严重程度增加相关,既往心脏骤停且年龄小于12岁的儿童发病率可能更高。

要点

  • 既往心脏骤停与儿科COVID-19重症风险升高相关(OR 9.92;95%CI 6.93-14.20),258例有心脏骤停史者中194例(75.19%)年龄小于12岁。
  • 心源性休克(OR 3.07;95%CI 1.90-4.96)和心脏手术史(OR 3.04;95%CI 2.26-4.08)也与重症COVID-19相关。
  • 心肺疾病(OR 1.91;95%CI 1.56-2.34)、心力衰竭(OR 1.82;95%CI 1.46-2.26)和低血压(OR 1.57;95%CI 1.38-1.79)与重症COVID-19相关。
  • 非创伤性脑出血(OR 1.54;95%CI 1.24-1.91)、心包炎(OR 1.50;95%CI 1.17-1.94)、单纯双心室缺陷(OR 1.45;95%CI 1.29-1.62)等也与重症相关。
  • 17 065例(9.96%)患者发生重症COVID-19,中位年龄8岁(IQR 2-14岁),男性占50.28%。

适用人群与场景

  • 美国85个医疗系统电子健康记录数据库中年龄2个月至17岁、实验室确诊COVID-19或诊断编码提示SARS-CoV-2感染或暴露的儿科患者,数据采集时间为2020年3月1日至2021年1月31日。
  • 暴露为2015年1月1日至2019年12月31日(SARS-CoV-2感染前)诊断的26种心血管疾病。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入171 416例儿科患者,中位年龄8岁(IQR 2-14岁),男性占50.28%,重症COVID-19(需要补充氧气或院内死亡)17 065例(9.96%)。
  • 混合效应随机截距logistic回归显示与重症COVID-19相关的条件:心脏骤停(OR 9.92;95%CI 6.93-14.20)、心源性休克(OR 3.07;95%CI 1.90-4.96)、心脏手术(OR 3.04;95%CI 2.26-4.08)、心肺疾病(OR 1.91;95%CI 1.56-2.34)、心力衰竭(OR 1.82;95%CI 1.46-2.26)、低血压(OR 1.57;95%CI 1.38-1.79)、非创伤性脑出血(OR 1.54;95%CI 1.24-1.91)、心包炎(OR 1.50;95%CI 1.17-1.94)、单纯双心室缺陷(OR 1.45;95%CI 1.29-1.62)、静脉栓塞和血栓形成(OR 1.39;95%CI 1.11-1.73)、其他高血压性疾病(OR 1.34;95%CI 1.09-1.63)、复杂双心室缺陷(OR 1.33;
  • 258例有心脏骤停史的患者中,194例(75.19%)年龄小于12岁。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,部分既往或既存心血管疾病与美国儿科患者COVID-19严重程度增加相关,既往心脏骤停且年龄小于12岁的儿童发病率可能更高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Identifying the associations between severe COVID-19 and individual cardiovascular conditions in pediatric patients may inform treatment.

OBJECTIVE: To assess the association between previous or preexisting cardiovascular conditions and severity of COVID-19 in pediatric patients.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used data from a large, multicenter, electronic health records database in the US. The cohort included patients aged 2 months to 17 years with a laboratory-confirmed diagnosis of COVID-19 or a diagnosis code indicating infection or exposure to SARS-CoV-2 at 85 health systems between March 1, 2020, and January 31, 2021.

EXPOSURES: Diagnoses for 26 cardiovascular conditions between January 1, 2015, and December 31, 2019 (before infection with SARS-CoV-2).

MAIN OUTCOMES AND MEASURES: The main outcome was severe COVID-19, defined as need for supplemental oxygen or in-hospital death. Mixed-effects, random intercept logistic regression modeling assessed the significance and magnitude of associations between 26 cardiovascular conditions and COVID-19 severity. Multiple comparison adjustment was performed using the Benjamini-Hochberg false discovery rate procedure.

RESULTS: The study comprised 171 416 pediatric patients; the median age was 8 years (IQR, 2-14 years), and 50.28% were male. Of these patients, 17 065 (9.96%) had severe COVID-19. The random intercept model showed that the following cardiovascular conditions were associated with severe COVID-19: cardiac arrest (odds ratio [OR], 9.92; 95% CI, 6.93-14.20), cardiogenic shock (OR, 3.07; 95% CI, 1.90-4.96), heart surgery (OR, 3.04; 95% CI, 2.26-4.08), cardiopulmonary disease (OR, 1.91; 95% CI, 1.56-2.34), heart failure (OR, 1.82; 95% CI, 1.46-2.26), hypotension (OR, 1.57; 95% CI, 1.38-1.79), nontraumatic cerebral hemorrhage (OR, 1.54; 95% CI, 1.24-1.91), pericarditis (OR, 1.50; 95% CI, 1.17-1.94), simple biventricular defects (OR, 1.45; 95% CI, 1.29-1.62), venous embolism and thrombosis (OR, 1.39; 95% CI, 1.11-1.73), other hypertensive disorders (OR, 1.34; 95% CI, 1.09-1.63), complex biventricular defects (OR, 1.33; 95% CI, 1.14-1.54), and essential primary hypertension (OR, 1.22; 95% CI, 1.08-1.38). Furthermore, 194 of 258 patients (75.19%) with a history of cardiac arrest were younger than 12 years.

CONCLUSIONS AND RELEVANCE: The findings suggest that some previous or preexisting cardiovascular conditions are associated with increased severity of COVID-19 among pediatric patients in the US and that morbidity may be increased among individuals children younger than 12 years with previous cardiac arrest.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Ehwerhemuepha L, Roth B, Patel AK, et al. Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in the US. JAMA Netw Open. 2022. PMID: 35579899. doi:10.1001/jamanetworkopen.2022.11967

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。